glp 1 available in india GLP-1 Drugs India: 5× Market Growth by 2030 GLP-1 Drug Misuse in India:

Recent studies have recognized the dual anti-inflammatory and glycemic control properties of teneligliptin, which imply that it may have additional benefits aside from glucose control [23]

For them, this is one more factor on the benefit side of a decision that already had real benefits

Holistic Insights Through Multi-Omics Platforms Multi-omics approaches enable the simultaneous interrogation of metabolic flux, gene expression, and protein abundance, providing a comprehensive understanding of how BBR orchestrates systemic physiological changes

Second-generation oral semaglutide, whose bioavailability and safety have been significantly improved by the application of new excipients and formulation optimization, but its gastrointestinal side effects are still obvious (Nielsen et al., 2025)

These changes result in extending semaglutide half-life to approximately 1 week, thus permitting a weekly delivery dosage scheme

Changes in the local microenvironment within metabolic organs have a significant impact on the function of tissue-resident and newly recruited macrophages, leading to metabolic inflammation linked to obesity (Wculek et al., 2022)